It is being tested in this Phase 2 double-blind, placebo-controlled multicenter RCT (NCT05731128) to evaluate its efficacy and safety in participants aged 18 years and older with moderately to severely active UC that has an eosinophilic phenotype
H., Pagotto, U.,
Personalized Care at Centra Internal Medicine : If you are struggling with weight management or blood sugar control, our team at Centra Internal Medicine will work with you to determine if tirzepatide is right for your needs
This information helps your provider identify factors affecting your response and develop an appropriate plan, whether that involves dose adjustment, additional testing for underlying conditions, referral to a dietitian or behavioral specialist, or consideration of alternative or adjunctive treatments
Since GLP-1 medications reduce appetite and slow stomach emptying, eating a large meal right before you exercise could be uncomfortable, says Adams
Zinc also supports how cells respond to insulin, helping glucose move from the bloodstream into cells more efficiently